Campbell WC et al., 1983-08-26: Merck's review of ivermectin's origin, spectrum and mechanism at the point of veterinary commercialisation.
Ivermectin is the 22,23-dihydro derivative of avermectin B1, a macrocyclic lactone produced by an actinomycete, Streptomyces avermitilis.
823
Campbell WC et al., 1983-08-26: Merck's review of ivermectin's origin, spectrum and mechanism at the point of veterinary commercialisation. C1 Campbell 1983. Study type: review. Country: USA (Merck Institute for Therapeutic Research). Funder: not stated; all authors Merck employees. Conflicts: none declared. Also states that human studies were then preliminary: 'it is not yet known whether ivermectin will be useful in human medicine.' Study type: review.
